Web31 Aug 2024 · On 8 July 2024, professor Rolf Hultcrantz passed away at the age of 72 years following a tough struggle with cancer. Already during medical school at Karolinska Institutet, Rolf was involved in research combining experimental and clinical work and obtained his PhD in 1982 for studies on hepatic effects of iron overload. Web22 Sep 2024 · Torbjörn Thulin, Ulf Strömberg, Anders Holmén, Rolf Hultcrantz, and Anna Forsberg. Journal of Medical Screening 2024 28: 3, 244-251 Download Citation. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and …
Requirements and standards facilitating quality improvement for …
WebIn the first study we investigated whether the use of a second generation contrast agent in ultrasound (US) examinations can improve detection of hepatocellular carcinoma (HCC) an WebRolf Hultcrantz Background Screening for colorectal cancer is done with lower gastrointestinal endoscopy or stool-based tests. There is little evidence from randomised … darlington cobra
In memoriam: Rolf Hultcrantz (1949-2024). - Abstract
Web31 Aug 2024 · In memoriam: Rolf Hultcrantz (1949–2024) August 2024 License CC BY-NC-ND 4.0 Authors: Hannes Hagström Magnus Simrén Anders Ekbom Discover the world's research Available via license: CC BY-NC-ND... Web28 Jul 2014 · Johannes Blom, Sini Kilpeläinen, Rolf Hultcrantz, and Sven Törnberg. Journal of Medical Screening 2014 21: 3, 144-150 Download Citation. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download. WebRolf Hultcrantz,7 and Rohit Loomba1,2 Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease (NAFLD). Quantitative risk of mortality by fibrosis stage has not been systematically evaluated. We aimed to quantify the fibrosis stage–specific risk of all-cause and liver-related mortality in NAFLD. mark a. molitoris